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Morphogens act in developing tissues to control the spatial
arrangement of cellular differentiation1,2. The activity of a mor-
phogen has generally been viewed as a concentration-dependent
response to a diffusible signal, but the duration of morphogen
signalling can also affect cellular responses3. One such example
is the morphogen sonic hedgehog (SHH). In the vertebrate central
nervous system and limbs, the pattern of cellular differentiation is
controlled by both the amount and the time of SHH exposure4–7.
How these two parameters are interpreted at a cellular level has
been unclear. Here we provide evidence that changing the concen-
tration or duration of SHH has an equivalent effect on intracellu-
lar signalling. Chick neural cells convert different concentrations
of SHH into time-limited periods of signal transduction, such that
signal duration is proportional to SHH concentration. This
depends on the gradual desensitization of cells to ongoing SHH
exposure, mediated by the SHH-dependent upregulation of
patched 1 (PTC1), a ligand-binding inhibitor of SHH signalling8.
Thus, in addition to its role in shaping the SHH gradient8–10, PTC1
participates cell autonomously in gradient sensing. Together, the
data reveal a novel strategy for morphogen interpretation, in
which the temporal adaptation of cells to a morphogen integrates
the concentration and duration of a signal to control differential
gene expression.
How both concentration and duration of morphogen signalling
determine cell pattern is poorly understood1 (see Supplementary Fig.
1a). We focused on three transcription factors that respond to dif-
ferential SHH signalling in progenitors of the neural tube. OLIG2 and
NKX2.2, expressed in the ventral neural tube of chick (Fig. 1a),
depend on SHH signalling for their expression4,11,12. In contrast,
PAX7 expression is repressed by SHH signalling13 and is restricted
to dorsal neural tube progenitors (Fig. 1a). We confirmed that these
proteins respond to different levels of SHH signalling using an ex vivo
assay of intermediate region naive neural plate explants14 (Fig. 1b–d).
In agreement with previous studies13,15, changes in SHH concentra-
tion controlled the expression of these genes in a manner corres-
ponding to their in vivo expression patterns (Fig. 1e). Similar gene
expression responses were obtained by generating, in vivo, a gradient
of GLI transcriptional activity16,17, the transcriptional effectors of
SHH signalling. Furthermore, manipulation of the activity of the
transmembrane protein smoothened (SMO), which transduces
SHH signalling intracellularly18, was also sufficient to confer graded
responses to neural cells (Supplementary Fig. 2).
We asked how the response of cells to SHH develops over time.
We assayed intermediate region neural plate explants exposed to
SHH for 6 h to 24 h (Fig. 1f, g and Supplementary Table 1).
NKX2.2 induction was delayed compared to OLIG2, taking .12 h
compared to ,6 h for OLIG2. Moreover, NKX2.2-inducing concen-
trations of SHH ($2 nM) produced a transient expression of OLIG2
(Fig. 1f, g). Thus, during the first 12 h, $1 nM SHH generated similar
amounts of OLIG2 induction (Supplementary Table 1). Only after
12 h were distinct responses apparent. By 18 h, OLIG2 and NKX2.2
co-expression was evident in some progenitors treated with $2 nM
SHH (Fig. 1f). These results are consistent with the sequential onset of
OLIG2 and NKX2.2 expression in vivo10,17. Furthermore, the explant
data predict that, in vivo, NKX2.2 should be induced in cells that
previously expressed OLIG2. Genetic lineage tracing in mice harbour-
ing an Olig2 allele engineered to encode Cre recombinase confirmed
this (Fig. 1h). Thus, compared to OLIG2, induction of NKX2.2
requires a higher concentration and longer duration of SHH exposure.
To investigate the reason for the temporal and concentration
dependence of the response, we analysed the output of the SHH signal
transduction pathway. We assayed GLI activity using a reporter plas-
mid19 (GBS-Luc; see Fig. 2a and Methods). Taking advantage of the
short half-life of luciferase20 (,3 h), we measured GBS-Luc activity
every 6 h. For concentrations of SHH $1 nM, GLI activity was similar
during the first 12 h (Fig. 2a), the period when these concentrations
induce OLIG2. Then, with the exception of the highest SHH concen-
tration, GLI activity decreased over time, with a rate inversely propor-
tional to SHH concentration (Fig. 2a). Notably, the time at which
1 nM and 4 nM SHH produced differences in the level of GLI activity
corresponded to the detection of differences in gene expression
(Fig. 1f, g and Supplementary Table 1). The data indicate, therefore,
that cells become progressively desensitized to ongoing SHH signal-
ling (Supplementary Fig. 1). Initially 1 nM and 4 nM SHH produce
similar levels of GLI activity, then the level of GLI activity begins to fall,
with a higher rate of decrease in cells exposed to lower concentrations.
This suggests a mechanism for gradient sensing in which ‘temporal
adaptation’ to the ligand transforms the extracellular concentration of
morphogen into a time-limited period of signal transduction, such
that the duration of signalling is proportional to ligand concentration.
This model predicts that the response of cells relies not only on the
level but also on the duration of intracellular signal transduction. To
test this, we compared GLI activity and gene expression in neural cells
containing an endogenous source of SHH. In explants consisting of
SHH-producing notochord and floor plate together with ventral
regions of the neural tube (hereafter called NVF explants), the expres-
sion of OLIG2 and NKX2.2 was induced sequentially, 12 h and 18 h
after the start of culture, respectively (Fig. 2f–h). During this period
the level of GLI activity remained approximately constant, confirming
that the switch to NKX2.2 expression was not associated with an
increase in GLI activity (Fig. 2b, f–h). To examine whether the main-
tenance of an OLIG2-expressing state depends on the downregulation
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of GLI activity, NVF explants were cultured for 12 h and then trans-
ferred to media containing cyclopamine, a small-molecule antagonist
of SHH signalling (Supplementary Fig. 2). GLI activity and gene
expression were monitored at 18 h (Fig. 2c–e, i). Addition of
200 nM cyclopamine at 12 h resulted in a twofold decrease in GLI
activity and a failure to induce NKX2.2 expression (Fig. 2c, e, i) with-
out inhibiting OLIG2 expression. Furthermore, addition of 400 nM
cyclopamine inhibited GLI activity to background levels, leading to a
complete loss of NKX2.2 expression and a decrease in the number of
OLIG2-expressing cells (Fig. 2c, e, and data not shown). These data
indicate that the duration of GLI activity is crucial for determining the
cellular response to SHH. To test the converse prediction of the model,
we assayed the effect of extending the period of SHH signalling
(Fig. 2j). Consistent with the model, prolonging SHH signalling
resulted in peak OLIG2 and NKX2.2 induction at lower SHH con-
centrations after 48 h of exposure compared to 24 h and 36 h (Fig. 2j).
Two mechanisms that could account for the adaptation of cells
to SHH signalling are the loss of a factor necessary for signal transduc-
tion or the induction of inhibitors of signal transduction, such as the
SHH-binding protein PTC1 (refs 21–23). We assessed GLI activity in a
time series of intermediate region neural plate explants in which SHH
signalling was induced using purmorphamine, a small-molecule ago-
nist of SMO24 (Fig. 3a and Supplementary Fig. 2). In contrast to the
response of neural cells to SHH (Fig. 2a), even though a diminution in
GLI activity was observed in treated cells, there was no correlation
between the rate of decrease and the concentration of purmorphamine
(Fig. 3a). This suggests that the profile of GLI activity evoked by SHH is
shaped mainly by an adaptation mechanism acting upstream of SMO.
As PTC1 is a well-established inhibitor of SHH signalling8, we tested
whether it is required cell autonomously for the temporal adaptation of
cells to SHH. Small interfering RNAs (siRNAs) were used to block
chick PTC1 (cPTC1) induction (Fig. 3b and Supplementary Figs
3–6). In ovo transfection of cPTC1 siRNAs inhibited the upregulation
of cPTC1 but did not completely abolish its expression (Supplementary
Fig. 4, and data not shown). As a result, and consistent with observa-
tions in mouse embryos containing an un-inducible allele of Ptc110,
ventralization of the neural tube, but no ligand-independent SHH
signalling, was observed in siRNA-transfected embryos or in inter-
mediate region neural plate explants (Supplementary Figs 3 and 5).
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Figure 1 | The temporal and concentration dependence of the response of
neural cells to SHH. a, PAX7, OLIG2 and NKX2.2 expression in HH stage 19
chick neural tube (scale bar, 50 mm). b–d, Intermediate region neural plate
explants cultured for 24 h in the indicated concentrations of SHH and
assayed simultaneously for the expression of PAX7, OLIG2 and NKX2.2.
OLIG2 expression decreases as NKX2.2 is induced, consistent with the
ability of NKX2.2 to repress OLIG212. e, Quantification of cells expressing
PAX7, OLIG2 and NKX2.2 in intermediate region neural plate explants
(n $ 5; number of cells per unit 6 s.d.). f, PAX7, OLIG2 and NKX2.2
expression in intermediate region neural plate explants grown with 4 nM
SHH for 6 h, 12 h, 18 h or 24 h (scale bar, 100mm). g, Quantification of cells
expressing OLIG2 and NKX2.2 in intermediate region neural plate explants
(n $ 5; number of cells per unit 6 s.d.). h, As well as OLIG21 progenitors,
NKX2.21 progenitors express LacZ in Olig2Cre/1;ROSA26-flox-STOP-flox-
lacZ E10.5 mouse embryos.
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Figure 2 | Sustained GLI activity is required for discrimination between
OLIG2 and NKX2.2 gene induction. a, GLI activity (relative GLI activity
6 s.e.m.) measured with GBS-Luc in intermediate region neural plate
explants treated with the indicated concentrations of SHH for the designated
times. GLI activity is measured relative to untreated explants. b, GLI activity
(relative GLI activity 6 s.e.m.) assayed in cells exposed to an endogenous
source of SHH. GBS-Luc assays were performed using NVF explants
(d) compared to intermediate region neural plate explants, which lack SHH
expression. c, Graph of relative GLI activity 6 s.e.m. according to conditions
in d (P-values from student’s t-test). Cyc., cyclopamine. Decreasing the
duration of GLI activity in NVF explants alters gene expression
(e, i). e, Quantification of OLIG21 and NKX2.21 cells relative to control
condition (18 h culture; 6 s.d.) in NVF explants. f–h, Temporal profile of
NKX2.2 and OLIG2 expression in NVF explants. j, Numbers of cells
expressing OLIG2 (red) and NKX2.2 (green) in intermediate region neural
plate explants (n $ 5; number of cells per unit 6 s.d.) exposed to the










































































































Figure 3 | A cell autonomous function for PTC1-mediated desensitization is
required for gradient sensing. a, Temporal profile of GLI activity, measured
with GBS-Luc, in intermediate region neural plate explants treated with the
indicated concentrations of purmorphamine for the designated times
(relative GLI activity 6s.e.m.). b, Blocking cPTC1 upregulation disrupts the
interpretation of high concentrations of SHH. Control or cPTC1 siRNA
electroporated intermediate region neural plate explants where cultured
with the indicated concentrations of SHH for 24 h and assayed for NKX2.2
and OLIG2 (scale bar, 25mm; n 5 10 for control siRNA; n 5 12 for cPTC1
siRNAs). c, A model for the morphogen patterning of a tissue divided into
three domains characterized by differential gene expression (A, B and C).
Graded morphogen signalling (M) from the source (S) is transduced into an
episode of signal transduction (signal output). Initially, each M
concentration ([M]) generates similar levels of signal output. However,
signal output declines more rapidly in cells exposed to lower [M]. Similar
profiles of signal output can be generated by a sustained [M] or by transient
exposure to M (variable [M]). This model illustrates how two different
parameters of a graded morphogen—amount of ligand and duration of
exposure—are transformed to an equivalent output by a responding cell.
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the response of cells to SHH exposure. Explants were transfected with
control or cPTC1 siRNAs and exposed to 0.25–1 nM SHH. Trans-
fection of control siRNAs did not change the gene expression profile
induced by SHH (Fig. 3b). However, in contrast to control explants
exposed to 1 nM SHH that predominately expressed OLIG2, increased
numbers of NKX2.2-expressing cells were observed in 1 nM SHH-
treated intermediate region neural plate explants transfected with
cPTC1 siRNAs. A similar result was obtained when siRNAs were trans-
fected individually (Supplementary Fig. 6). The siRNA effect was
dependent on SHH concentration: cPTC1 siRNAs did not alter the
response of intermediate region neural plate explants exposed to
,0.5 nM SHH, indicating that the blockade of cPTC1 upregulation
does not result in NKX2.2 induction in response to all concentrations of
SHH. These data indicate that gradient sensing requires upregulation of
PTC1. This complements the previously identified ability of PTC1 to
influence the spread of ligand by sequestering SHH protein8–10. Thus,
upregulation of PTC1 by SHH has both cell autonomous and non-
autonomous functions in morphogen interpretation.
Adaptation to extracellular signals has previously been proposed
to permit the sensing and transduction of a signal over large concen-
tration ranges25,26. This study indicates that the same strategy is used
to measure the concentration of a ligand during developmental pat-
terning. The progressive adaptation of cells to SHH transforms ligand
exposure into periods of increased GLI activity, the duration of which
is proportional to SHH concentration (Fig. 3c). This allows cells to
integrate both the concentration and duration of a graded morpho-
gen (Supplementary Fig. 1). The transduction of a morphogen
concentration into a duration of transcriptional activity offers an
alternative to the established mechanisms of graded signalling27,28,
which explains how the amount and duration of SHH exposure
determine similar cellular responses3,6,7.
METHODS SUMMARY
Neural plate explants, immunohistochemistry and in situ hybridization.
Explants isolated from Hamburger and Hamilton (HH) stage 10 chick embryos
were cultured as described13,14. Cyclopamine (Toronto Research Chemicals) and
purmorphamine (Calbiochem) were dissolved in 100% ethanol and DMSO,
respectively. Reagents and protocols for immunohistochemistry and in situ
hybridization have been described12–14,29.
Chick in ovo electroporation, luciferase assays and siRNAs. HH stage 10
embryos were electroporated in ovo and incubated for 2 h before dissecting
explants. Luciferase assays with GBS-Luc19 were carried out as previously
described17. RNA duplexes targeting chick PTC1 and, as a control, human lamin
were from Dharmacon. These were co-electroporated in ovo with a plasmid
expressing green fluorescent protein.
Olig2-Cre lineage tracing. Olig2-Cre mice were generated in the Jessell labor-
atory, Columbia University. Standard homologous recombination procedures
were used to replace exon 2 of the Olig2 locus with Cre recombinase. Olig2-Cre/
1 mice were mated with ROSA26 reporter mice30, and embryos analysed at E10.5.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Neural plate explant culture. Neural plate tissue was isolated from Hamburger
and Hamilton (HH) stage 10 chick embryos and cultured as described14. Explants
consisted of the intermediate region or the notochord, floor plate and adjacent
ventral region (NVF). SHH protein was generated as described15. Concentration
of SHH was determined by comparison with previous batches. Cyclopamine
(Toronto Research Chemicals) and purmorphamine (Calbiochem) were dis-
solved in 100% ethanol and DMSO, respectively. Quantifications of PAX7,
OLIG2 and NKX2.2 expressing cells were performed on representative unit
squares (containing 200 6 20 cells) in intermediate region neural plate explants
(n $ 5 explants for each data point).
Immunohistochemistry and in situ hybridization. Antibody reagents and pro-
tocols have been described12–14,29. The monoclonal antibodies against PAX6 and
PAX7 were obtained from the Developmental Studies Hybridoma Bank
(University of Iowa). Rabbit Nkx2.2 antibody31 (T. Jessell) was used at 1:5,000
and guinea-pig Olig2 antibody12 was used at 1:10,000. Mouse antibody for Tuj1
(Covance Research) and goat antibody for Sox2 (ISL) were used at 1:1,000 and
1:500, respectively. Sheep antibody for GFP (Biogenesis) and rabbit antibody for
GFP (Invitrogen) were used at 1:1,000. Analysis was carried out using a Leica
TCS SP2 confocal microscope or a Zeiss Axioplan 2 and processed with Adobe
Photoshop 7.0 software (Adobe Systems). In situ hybridization was performed as
described32 using a chick PTC1 probe33 labelled with DIG-labelling reagents
(Roche Diagnostics) and filtered NBT/BCIP substrate (Sigma) in 0.5% Tween
(Sigma).
Generation of cPTC1 siRNAs. RNA duplexes targeting cPTC1 mRNA were
ordered in 29 deprotected, annealed and desalted form (Option A4, http://
www.dharmacon.com). The RNA duplexes used in this study are: cPTC1
siRNA 1 sense 59-UGAGAGCUAUCUGCAAUAAUU-39; cPTC1 siRNA 2 sense
59-AUAUGGACCAGAUUAUAGAUU-39; cPTC1 siRNA 3 sense 59-CUAAUG-
UACUCACAACAGAUU-39. siRNA (target sequence 59-AACUGGACUUCC-
AGAAGAACA-39) against human lamin was used as control (Dharmacon).
Chick in ovo electroporation and luciferase assay in intermediate region
explants. HH stage 10 embryos were electroporated and incubated for 2 h before
dissecting intermediate region neural plate explants. For luciferase assays, the
firefly-luciferase reporter gene carrying eight copies of the GLI-binding site from
the FoxA2 floor plate enhancer (GBS-Luc) was used19. Chick embryos were co-
electroporated with GBS-Luc and CMV-Renilla luciferase normalization plas-
mid (Promega). Assays were carried out on explants as previously described17.
Explants were homogenized in passive lysis buffer on ice and measurement of
firefly and Renilla luciferase activities was performed using the Dual Luciferase
Reporter Assay System (Promega). Each point corresponds to triplicates of 7–10
explants. Short interfering RNAs were electroporated at 2.5mgml21 final con-
centration. The neural tube of embryos was co-injected with a plasmid expres-
sing GFP to control for electroporation efficiency.
Olig2-Cre lineage tracing. Standard homologous recombination procedures
were used to replace exon 2 of the Olig2 locus with a gene encoding a nuclear-
localized form of Cre recombinase. Details of the gene-targeting strategy are
available on request. Olig2-Cre/1 mice were mated with ROSA26 reporter
mice30, and embryos were collected at E10.5 and subjected to immuno-
histochemical analysis as described above.
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